Importin
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
</StructureSection> | </StructureSection> | ||
| - | |||
| - | ==3D structures of importin== | ||
| - | |||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *IPO-α | ||
| - | |||
| - | **[[1ial]] – mIPO NLS-binding domain – mouse<br /> | ||
| - | **[[1bk5]] – yIPO NLS-binding domain - yeast<br /> | ||
| - | **[[4tnm]] – IPO armadillo repeat domain – ''Arabidopsis thaliana''<br /> | ||
| - | |||
| - | *''IPO-α complex with NLS peptide'' | ||
| - | |||
| - | **[[1ejl]] – mIPO NLS-binding domain + SV40 large T antigen<br /> | ||
| - | **[[1ejy]] – mIPO NLS-binding domain + nucleoplasmin <br /> | ||
| - | **[[2ynr]] – mIPO NLS-binding domain + B54NLS <br /> | ||
| - | **[[2yns]] – rIPO NLS-binding domain + B54NLS - rice<br /> | ||
| - | **[[1bk6]] – yIPO NLS-binding domain + SV40 large T antigen<br /> | ||
| - | **[[1ee4]] – yIPO NLS-binding domain (mutant) + c-Myc<br /> | ||
| - | **[[1ee5]] – yIPO NLS-binding domain (mutant) + nucleoplasmin<br /> | ||
| - | **[[1un0]], [[2c1t]] – yIPO NLS-binding domain (mutant) + Nup2<br /> | ||
| - | **[[5h2x]], [[5h2w]] – yIPO NLS-binding domain + ubiquitin-like specific protease<br /> | ||
| - | **[[4xzr]] – yIPO NLS-binding domain + HEH1<br /> | ||
| - | **[[4pvz]] – yIPO NLS-binding domain + HEH2<br /> | ||
| - | **[[4rxh]] – NcIPO NLS-binding domain + SV40 large T antigen – ''Neurospora crassa''<br /> | ||
| - | **[[5vqi]] – NcIPO NLS-binding domain + NIT2<br /> | ||
| - | |||
| - | *''IPO-α complex with protein'' | ||
| - | |||
| - | **[[1wa5]] – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter<br /> | ||
| - | **[[5t94]] – yIPO NLS-binding domain + guanine nucleotide exchange factor <br /> | ||
| - | **[[5mfm]] – yIPO NLS-binding domain + YIIIM6AII <br /> | ||
| - | |||
| - | *IPO-α 1 | ||
| - | |||
| - | **[[3wpt]] – hIPO NLS-binding domain - human<br /> | ||
| - | **[[4b8j]] – rIPO <br /> | ||
| - | **[[6bvt]] – mIPO NLS-binding domain <br /> | ||
| - | |||
| - | *''IPO-α 1 complex with NLS peptide'' | ||
| - | |||
| - | **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | ||
| - | **[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | ||
| - | **[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | ||
| - | **[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
| - | **[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | ||
| - | **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | ||
| - | **[[4mz5]], [[4mz6]] – mIPO NLS-binding domain + dUTPase<br /> | ||
| - | **[[4oih]] – mIPO NLS-binding domain + guanine nucleotide exchange factor SRM1<br /> | ||
| - | **[[5svz]] – mIPO NLS-binding domain + TAT NLS motif<br /> | ||
| - | **[[5wum]], [[5wun]], [[5x8n]] – mIPO NLS-binding domain + Epstein Barr antigen<br /> | ||
| - | **[[5huw]] – mIPO NLS-binding domain + HSVI large terminase<br /> | ||
| - | **[[5huy]] – mIPO NLS-binding domain + HSMV small terminase<br /> | ||
| - | **[[5hhg]], [[5fc8]] – mIPO NLS-binding domain + dengue 2 NS5<br /> | ||
| - | **[[5ekg]], [[5ekf]], [[5e6q]] – mIPO NLS-binding domain + XPG2<br /> | ||
| - | **[[5d5k]] – mIPO NLS-binding domain + PARP 2<br /> | ||
| - | **[[5ctt]] – mIPO NLS-binding domain + SART3/TIP110<br /> | ||
| - | **[[5b56]] – mIPO NLS-binding domain + HIV-1 VPR<br /> | ||
| - | **[[4zdu]] – mIPO NLS-binding domain + influenza nucleoprotein<br /> | ||
| - | **[[4yi0]] – mIPO NLS-binding domain + Nup121<br /> | ||
| - | **[[5klr]], [[5klt]] – mIPO NLS-binding domain + NLS <br /> | ||
| - | **[[5k9s]] – mIPO NLS-binding domain + HNF-b <br /> | ||
| - | **[[6iu7]], [[6iua]] – mIPO NLS-binding domain + TP53-binding protein <br /> | ||
| - | **[[5w41]] – mIPO NLS-binding domain + Zika virus peptide <br /> | ||
| - | **[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | ||
| - | **[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | ||
| - | **[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> | ||
| - | **[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | ||
| - | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | ||
| - | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | ||
| - | **[[4bpl]] – rIPO NLS-binding domain + nucleoplasmin<br /> | ||
| - | **[[4bqk]] – rIPO NLS-binding domain + VirD2<br /> | ||
| - | |||
| - | *''IPO-α 1 complex with protein'' | ||
| - | |||
| - | **[[2jdq]] – hIPO NLS-binding domain + polymerase basic protein 2 C terminal<br /> | ||
| - | **[[3tj3]] – hIPO NLS-binding domain + Nup50 N terminal<br /> | ||
| - | **[[2jdq]] – hIPO NLS-binding domain + telomerase reverse transcriptase peptide<br /> | ||
| - | **[[4uaf]] – mIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
| - | |||
| - | *IPO-α 2 | ||
| - | |||
| - | **[[3tpo]] – mIPO<br /> | ||
| - | **[[1iq1]] – mIPO NLS-binding + autoinhibitory peptide domains<br /> | ||
| - | **[[4e4v]] – hIPO NLS-binding domain (mutant) <br /> | ||
| - | |||
| - | *''IPO-α 2 complex with NLS peptide'' | ||
| - | |||
| - | **[[1pjm]] – mIPO NLS-binding domain + retinoblastoma-associated protein<br /> | ||
| - | **[[1pjn]] – mIPO NLS-binding domain + histone-binding protein N1/N2<br /> | ||
| - | **[[1q1s]], [[1q1t]] – mIPO NLS-binding domain + SV40 large T antigen<br /> | ||
| - | **[[1y2a]], [[3q5u]] – mIPO NLS-binding domain + phospholipid scramblase <br /> | ||
| - | **[[2c1m]] – mIPO NLS-binding domain + Nup50<br /> | ||
| - | **[[3btr]] – mIPO NLS-binding domain + androgen receptor<br /> | ||
| - | **[[3knd]] – mIPO NLS-binding domain + targeting protein for KXLP2<br /> | ||
| - | **[[3l3q]] – mIPO NLS-binding domain + library peptide<br /> | ||
| - | **[[3oqs]] – mIPO NLS-binding domain + CLIC4<br /> | ||
| - | **[[3rz9]] – mIPO NLS-binding domain + KU80<br /> | ||
| - | **[[3rzx]] – mIPO NLS-binding domain + KU70<br /> | ||
| - | **[[3tpm]] – mIPO NLS-binding domain + MAL<br /> | ||
| - | **[[3ve6]] – mIPO NLS-binding domain + Venezuelan equine encephalitis virus<br /> | ||
| - | **[[3uvu]] – mIPO NLS-binding domain + flap endonuclease<br /> | ||
| - | **[[3ukw]], [[3ukx]] – mIPO NLS-binding domain + BIMAX<br /> | ||
| - | **[[3uky]], [[3ukz]], [[3ul0]] – mIPO NLS-binding domain + nuclear CAP-binding protein<br /> | ||
| - | **[[3ul1]] – mIPO NLS-binding domain + nucleoplasmin <br /> | ||
| - | **[[4htv]] – mIPO NLS-binding domain + capsid protein <br /> | ||
| - | **[[4ba3]] – mIPO NLS-binding domain + A89NLS <br /> | ||
| - | **[[3zio]], [[3zip]], [[3ziq]], [[3zir]] – mIPO NLS-binding domain + minor site-specific NLS <br /> | ||
| - | **[[3zin]] – mIPO NLS-binding domain + nucleolar RNA helicase<br /> | ||
| - | |||
| - | *''IPO-α 2 complex with protein'' | ||
| - | |||
| - | **[[3fex]], [[3fey]] – mIPO NLS-binding domain + nuclear CAP-binding protein<br /> | ||
| - | |||
| - | *IPO-α 3 | ||
| - | |||
| - | **[[6bvz]] – hIPO NLS-binding domain <br /> | ||
| - | **[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
| - | **[[6bw9]], [[6bwa]], [[6bwb]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
| - | **[[6bvv]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | ||
| - | **[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | ||
| - | **[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | ||
| - | |||
| - | *IPO-α 6 | ||
| - | |||
| - | **[[4u2x]] – hIPO C terminal + ebola VP24<br /> | ||
| - | |||
| - | *IPO-α 7 | ||
| - | |||
| - | **[[4uad]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
| - | |||
| - | *IPO-β | ||
| - | |||
| - | **[[4xrk]] – IPO – ''Chaetomium thermophilum'' <br /> | ||
| - | |||
| - | *IPO-β 1 (karyopherin β 1) | ||
| - | |||
| - | **[[3nd2]] – yIPO <br /> | ||
| - | **[[1gcj]] – mIPO N terminal<br /> | ||
| - | |||
| - | *''IPO-β 1 complex with protein'' | ||
| - | |||
| - | **[[1qgx]], [[1qgk]] – hIPO + IPO-α 2 IBB domain<br /> | ||
| - | **[[1ibr]] – hIPO + GTPase Ran<br /> | ||
| - | **[[2bku]], [[3ea5]] – yIPO + GTPase Ran<br /> | ||
| - | **[[1f59]], [[1o6p]], [[1o6o]] – hIPO + FXFG nucleoporin repeats<br /> | ||
| - | **[[1m5n]] – hIPO HEAT repeats 1-11 + parathyroid hormone-related protein NLS peptide<br /> | ||
| - | **[[2p8q]], [[2q5d]], [[2qna]], [[3lww]] – hIPO + RNA U transporter N terminal<br /> | ||
| - | **[[1qgr]], [[3w5k]] – hIPO + zinc finger protein SNAI1<br /> | ||
| - | **[[5owu]] – yIPO + Nup1<br /> | ||
| - | **[[1ukl]] – mIPO + SREBP-2<br /> | ||
| - | |||
| - | *IPO-β 2 (Transportin 1) | ||
| - | |||
| - | **[[2z5j]], [[2qmr]] – hIPO <br /> | ||
| - | |||
| - | *''IPO-β 2 complex with protein'' | ||
| - | |||
| - | **[[2h4m]], [[2ot8]], [[2z5n]] – hIPO + hnRNP peptide<br /> | ||
| - | **[[2z5k]], [[2z5m]] – hIPO + nuclear RNA export factor peptide<br /> | ||
| - | **[[2z5o]] – hIPO + JKTBP peptide<br /> | ||
| - | **[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | ||
| - | **[[5yvg]], [[5yvh]] – hIPO + FUS <br /> | ||
| - | **[[5vyh]], [[5vyi]] – hIPO + FUS peptide<br /> | ||
| - | **[[4fq3]] – hIPO + FUS peptide<br /> | ||
| - | **[[5tqc]] – hIPO + RPL4 peptide<br /> | ||
| - | **[[5j3v]] – hIPO + histone H3 peptide<br /> | ||
| - | |||
| - | *IPO-β 3 (Karyopherin β 3) | ||
| - | |||
| - | **[[3w3t]] – yIPO <br /> | ||
| - | **[[3w3u]], [[3w3v]] – yIPO (mutant)<br /> | ||
| - | **[[3w3w]] – yIPO + STE12P<br /> | ||
| - | **[[3w3x]] – yIPO + PHO4<br /> | ||
| - | **[[3w3y]] – yIPO + Nup53P<br /> | ||
| - | **[[3w3z]] – yIPO + RANGTP<br /> | ||
| - | **[[5h2v]] – yIPO + ubiquitin-like specific protease<br /> | ||
| - | **[[4zj7]] – yIPO + CDC14<br /> | ||
| - | |||
| - | *IPO-4B | ||
| - | |||
| - | **[[5xah]] – hIPO residues 668-1081 <br /> | ||
| - | **[[5xbk]] – hIPO residues 668-1081 + histone H3 peptide <br /> | ||
| - | |||
| - | *IPO-7 | ||
| - | |||
| - | **[[6n88]] – IPO + hIPO-90 + histone H1.0 – frog – Cryo EM <br /> | ||
| - | |||
| - | *IPO-9 | ||
| - | |||
| - | **[[6n1z]] – hIPO + histone H2A + histone H2B <br /> | ||
| - | |||
| - | *IPO-12 (Transportin-3) | ||
| - | |||
| - | **[[4c0p]] – hIPO <br /> | ||
| - | **[[4c0o]] – hIPO + serine/arginine-rich splicing factor<br /> | ||
| - | **[[4c0q]], [[4ol0]] – hIPO + GTPase Ran<br /> | ||
| - | |||
| - | *IPO-13 (karyopherin 13) | ||
| - | |||
| - | **[[2x19]] – hIPO + GTPase Ran<br /> | ||
| - | **[[2xwu]] – hIPO + UBC9<br /> | ||
| - | **[[3zjy]] – hIPO + GTPase Ran + EIF-1A<br /> | ||
| - | |||
| - | *IPO-90 | ||
| - | |||
| - | **[[6n89]] – hIPO-90 + histone H1.0 – Cryo EM <br /> | ||
| - | }} | ||
== References == | == References == | ||
Revision as of 10:29, 27 August 2019
| |||||||||||
References
- ↑ Mattaj IW, Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem. 1998;67:265-306. PMID:9759490 doi:http://dx.doi.org/10.1146/annurev.biochem.67.1.265
- ↑ Pumroy RA, Cingolani G. Diversification of importin-alpha isoforms in cellular trafficking and disease states. Biochem J. 2015 Feb 15;466(1):13-28. doi: 10.1042/BJ20141186. PMID:25656054 doi:http://dx.doi.org/10.1042/BJ20141186

